Projects per year
Fingerprint
Dive into the research topics where Amarnath Natarajan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
pBACH1 binding site on BRCT(BRCA1): A novel approach to cancer therapeutics
Project: Research project
-
HTS to Identify Small Molecule Inhibitors of Phospho-Specific Protein-Protein Int
Project: Research project
-
Phosphorylated Form of Activated IKKbeta and Pancreatic Cancer
Project: Research project
-
Development of Quinoxaline Based IKKbeta Inhibitors for Kras Driven Cancers
Project: Research project
-
Research output
-
Selective CDK9 degradation using a proteolysis-targeting chimera (PROTAC) strategy
Mallareddy, J. R., Singh, S., Boghean, L. & Natarajan, A., Jan 2022, In: Future Medicinal Chemistry. 14, 3, p. 131-134 4 p.Research output: Contribution to journal › Review article › peer-review
1 Scopus citations -
Stapling proteins in the RELA complex inhibits TNFα-induced nuclear translocation of RELA
Kour, S., Rana, S., Kizhake, S., Lagundžin, D., Klinkebiel, D., Mallareddy, J. R., Huxford, T., Woods, N. T. & Natarajan, A., Jan 2022, In: RSC Chemical Biology. 3, 1, p. 32-36 5 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
The human AP-endonuclease 1 (APE1) is a DNA G-quadruplex structure binding protein and regulates KRAS expression in pancreatic ductal adenocarcinoma cells
Pramanik, S., Chen, Y., Song, H., Khutsishvili, I., Marky, L. A., Ray, S., Natarajan, A., Singh, P. & Bhakat, K. K., Apr 8 2022, In: Nucleic acids research. 50, 6, p. 3394-3412 19 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Aminopyrazole based CDK9 PROTAC sensitizes pancreatic cancer cells to venetoclax
King, H. M., Rana, S., Kubica, S. P., Mallareddy, J. R., Kizhake, S., Ezell, E. L., Zahid, M., Naldrett, M. J., Alvarez, S., Law, H. C. H., Woods, N. T. & Natarajan, A., Jul 1 2021, In: Bioorganic and Medicinal Chemistry Letters. 43, 128061.Research output: Contribution to journal › Article › peer-review
6 Scopus citations -
Inhibitors, protacs and molecular glues as diverse therapeutic modalities to target cyclin-dependent kinase
Rana, S., Mallareddy, J. R., Singh, S., Boghean, L. & Natarajan, A., Nov 1 2021, In: Cancers. 13, 21, 5506.Research output: Contribution to journal › Review article › peer-review
Open Access3 Scopus citations